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Abstract: Traditionally, hazardous chemicals have been regulated in the U.S. on a one-by-one 
basis, an approach that is slow, expensive and can be inefficient, as illustrated by a  
decades-long succession of replacing one type of organohalogen flame retardants (OHFRs) 
with another one, without addressing the root cause of toxicity and associated public health 
threats posed. The present article expounds on the need for efficient monitoring strategies 
and pragmatic steps in reducing environmental pollution and adverse human health impacts. 
A promising approach is to combine specific bioassays with state-of-the-art chemical 
screening to identify chemicals and chemical mixtures sharing specific modes of action 
(MOAs) and pathways of toxicity (PoTs). This approach could be used to identify and 
regulate hazardous chemicals as classes or compound families, featuring similar biological 
end-points, such as endocrine disruption and mutagenicity. Opportunities and potential 
obstacles of implementing this approach are discussed. 
Keywords: environmental monitoring; flame retardants; regulatory framework; chemical 
mixtures; toxicity 
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1. Introduction 
Today, more than 84,000 chemicals are included in the U.S. Toxic Substances Control Act (TSCA) 
inventory, and approximately 10% of these chemicals are associated with cancer [1,2]. The majority of 
current environmental and biological monitoring strategies rely on chemical analysis of individual target 
compounds. Similarly, today’s chemical regulations in the U.S. and many other countries worldwide target 
specific chemicals rather than groups of compounds posing threats via specific pathways of toxicity that 
result in shared adverse outcomes in human health. Contrary to the single-chemical scenarios that inform 
risk assessments today, people in everyday life get exposed to multiple chemicals, which may exert 
cumulative effects on humans or interact in unpredictable ways via chemical interactions [1]. One major 
concern with chemical mixtures is the possibility of inducing synergistic effects, whose overall effects 
exceed the sum of adverse impacts caused by individual exposures. Synergistic effects resulting from the 
inhalation of radon progeny and smoking, and exposure to asbestos and smoking have been documented 
for lung cancer incidents [3,4]. Two classic approaches to address toxicity resulting from chemical 
mixtures are concentration addition (CA) and independent action (IA), for which information on both the 
individual chemical toxicity and concentration of the chemical in the respective mixture of interest is 
needed [5,6]. For example, the standard method for assessing mixture toxicity and exposures of  
dioxin-like compounds makes use of Toxic Equivalency Factors (TEF). This methodology expresses the 
composite chemical risk resultant from complex mixtures of dioxin-like compounds 
(polychlorinated/polybrominated dioxins, furans and biphenyls), in a single value, using as a benchmark 
the most toxic form of dioxin, i.e., 2,3,7,8-tetrachlorodibezo-p-dioxin (TCDD). The approach assumes 
that all dioxin-like compounds exhibit a similar profile of effect on the aryl hydrocarbon receptor (AhR), 
and that the effects are additive. However, research has shown that the presence of certain congeners 
(e.g., PCB 153) in mixtures antagonized the effects of TCDD, highlighting some major limitations for 
the use of additive TEF approach [7]. In addition, these approaches of estimating toxicity require 
extensive ecotoxicological data for individual chemicals and a thorough characterization of the chemical 
mixtures. An added concern is the presence of unknown production impurities in chemicals and 
unrecognized transformation products for which no current methods of detection are available, with 
these toxic analogs contributing to the observed toxicity.  
One important class of chemicals that exhibit mixture toxicity in the environment is the group of 
organohalogen flame retardants (OHFRs), particularly the various congeners of polybrominated 
diphenyl ethers (PBDEs). Among these, the large number of congeners, their varying toxicity (depending 
on the degree of halogenation), the possibility of inter-transformation of congeners from a higher to a 
lower halogenation state, and presence of impurities (such as dioxins and furans), make monitoring and 
legislative actions for OHFRs exceptionally complicated. Managing this group of problematic chemicals 
has proven to be a challenge, as indicated by 45 years of still ongoing legislative actions for PBDEs. 
Relevant challenges and legislative initiatives are highlighted in the following, using OHFRs as an 
illustrative case study of lessons learned from monitoring practices and chemical regulations. 
  
Int. J. Environ. Res. Public Health 2015, 12 10551 
 
 
2. Organohalogen Flame Retardants and Current Regulations  
Many OHFRs are known to be persistent, bioaccumulative and toxic, while also having been detected 
globally in the environment, in wildlife, and in human populations [8]. Following these concerns, two 
major commercial formulations of flame retardants, namely penta- and octa-brominated diphenyl ethers 
(BDEs), were banned by the European Union (EU) in 2002; the fully brominated deca-BDE later also was 
banned from use in electrical and electronic applications within the EU in 2008 [9,10]. In the U.S.,  
penta- and octa-BDEs were voluntarily phased-out in 2005 and deca-BDE sales were expected to cease 
by the end of 2013, with definitive numbers still pending. Regulating brominated flame retardants is and 
has been an ongoing challenge for the past 45 years, ever since their widespread use began in the 1970s 
(Figure 1). Even after ban and phase-out initiatives, many products manufactured with  
penta- through deca-BDEs prior to regulatory actions remain in use today. Replacement chemicals now 
finding their way into commerce are structurally similar to the original, now banned or phased-out 
compounds; not surprisingly, they show similar characteristics, including persistence, bioaccumulation 
potential and toxicity in the environment [9,11]. In general, all these chemicals feature one or more 
benzene rings with varying degrees of halogenation, a basic chemical structure endowing banned 
polychlorinated biphenyls (PCBs) and carcinogenic polychlorinated dibenzo-p-dioxins with their 
marked toxicity and endocrine disrupting characteristics. Four decades after being banned in the U.S., 
PCBs still are detected in most environments, wildlife and human populations, and BDE formulations 
are on a trajectory to persist for many decades following their recent ban [12,13]. In addition, the 
realization has set in more recently, that these mass produced OHFRs are transformed in the environment 
abiotically and biotically to various toxic transformation products, such as mono- and polyhydroxylated 
congeners of the manufactured parent compound [14–16]. Furthermore, structurally related impurities 
of similar toxicity have been known for quite some time to be present in commercial grade flame 
retardants used in the manufacturing of consumer products [17]. 
 
Figure 1. Timeline of legislative initiatives for brominated flame retardants spanning half a 
century of widespread use in industries. EU: European Union; OECD: Organisation for 
Economic Co-operation and Development; OSPAR: Oslo and Paris Conventions for the 
Protection of the Marine Environment of the North-East Atlantic; PBB: polybrominated 
biphenyls; PBDE: polybrominated diphenylether; POP: persistent organic pollutant; 
TBBPA: tetrabromobisphenol A; WHO: World Health Organization. 
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The solution to the problem of persistent chemical pollution ultimately is to curtail the use and 
production of compounds sharing a structural and functional similarity to known hazardous compounds. 
The futility of making minor modifications to the carbon backbone or halogen substitution pattern of 
persistent OHFRs and then hoping for a different, better outcome has been demonstrated over and over 
again. Pragmatic and prudent steps for reducing the unwanted environmental pollution and adverse 
human health impacts these chemicals pose include: 
• Avoiding the use of flame retardants in consumer products that do not pose a significant fire 
hazard in the first place; 
• Avoiding the use of flame retardants that resemble in molecular size and structure their  
harmful predecessors; 
• Developing for use in products that absolutely require them, next-generation flame retardants 
featuring the following characteristics while still delivering the desired flame retardation qualities: 
o covalently bound to the consumer products to minimize release and exposure, wherever 
possible and practical; 
o large molecular size (e.g., polymers) that limits and ideally precludes uptake by biota 
following environmental release [18]; 
o absence of size and shape characteristics contributing to affinity and binding to human and 
animal receptors, thereby reducing the risk of toxicity, for example, of endocrine disruption 
via binding to hormone receptors.  
A recent study by our group featured the use of municipal sewage sludge (a solid byproduct of 
wastewater treatment) for identifying and prioritizing persistent and bioaccumulative chemicals.  
Eight top priority chemicals of high abundance and bioaccumulative potential were identified; these 
included five organohalogens of which three were brominated flame retardants (BFRs) [19]. The BFRs 
were the third most abundant group of chemicals detected in nationally representative U.S. sewage 
sludges (among 239 compounds surveyed), suggesting their widespread use and ongoing exposures of 
human populations and wildlife. Also, the study revealed that among 55 potentially bioaccumulative 
chemicals detectable in sewage sludge, 93% were halogenated. It is well known that the replacement of 
hydrogen with halogen atoms is positively correlated with an increase in the chemical’s hydrophobicity, 
persistence and toxicity [20]. Our analysis of compounds included in the U.S. Safe Drinking Water Act 
of the U.S. EPA showed that 74 percent of regulated organic compounds carry at least one and more 
frequently multiple halogen substituents. 
With these facts firmly established, the following question arises: why are we continuing to design, 
manufacture and use organohalogen compounds that are known to be hazardous as a class or family? 
Instead of regulating individual formulations like penta- or octa-BDEs and replacing those with similar 
formulations like deca-BDE, a more proactive and protective strategy is required in chemical safety 
management. There is a need to recognize and circumvent the root cause that endows organic 
compounds, such as OHFRs, with the widely manifested potential for adverse effects, specifically 
persistence, bioaccumulation potential and toxicity. 
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3. Future Monitoring Strategies 
Future monitoring approaches can pave the way to creating and enforcing better regulations.  
They should include both chemical analyses and specific bioassays to identify anthropogenic chemical 
agents eliciting unwanted and unnecessary toxicity in the environment. These agents then could be 
targeted by more effective regulations zeroing in on chemical groups featuring similar modes of action 
(MOAs) and pathways of toxicity (PoTs). Techniques that identify specific interactions of chemical 
mixtures with human receptors or biological end-points (e.g., binding to thyroid hormone receptor and 
resultant endocrine disruption) will allow for an identification of biologically active groups of chemical 
in the environment. Examples of such approaches include effects-directed analysis (EDA), toxicity 
identification evaluation (TIE) and other pathway-based cellular and molecular assays [21–23]. EDA uses 
bioassays (typically in vitro) as tools to narrow down and sensitively detect organic chemical mixtures in 
the environment that contribute to an observed and measureable toxic effect. This is achieved by 
fractionation based on physical-chemical properties of the components to reduce the complexity of 
contaminant mixtures in the sample into prioritized sub-groups. TIE relies on whole-organism (e.g., 
daphnids, mysids) toxicity testing to enable a characterization of chemical mixtures into sub-classes, 
followed by identification and validation. EDA has the advantage of having high specificity in toxicant 
identification, since specific biological endpoints are studied via in vitro testing. Whereas TIE lacks 
specificity due to whole organism testing, it does however consider toxicant bioavailability 
considerations in the analysis. Currently, the U.S. EPA requires chemical testing from manufacturers 
and processors only if: (i) a chemical may present an unreasonable risk of injury to human health or 
environment; (ii) the chemical is produced in a substantial quantity that could result in significant 
environmental releases and human exposures; and/or (iii) the available data is inadequate [24]. However, 
these criteria may exclude many chemicals of low production volume, other transformation products, 
unidentified chemicals and chemical mixtures that might be of significant concern to human health and 
the environment.  Hence, incorporating EDA/TIE like bioassays into monitoring programs would be a 
prudent and promising approach to identify risks of injury to human health or the environment from 
chemical mixtures including unknowns, whose occurrence and harmful potential cannot be established 
purely on the basis of chemical monitoring of singular compounds. 
The U.S. EPA’s Computational Toxicology (CompTox) research aims to integrate advances in 
molecular biology, toxicology, and computer science to overcome limitations of traditional laboratory 
animal-based toxicity tests and to help prioritize chemicals through high-throughput screening assays via 
Toxicity Forecaster (ToxCast). This program relies on cell-based bioassays for screening of chemicals and 
to develop predictive models for health outcomes [25]. Application of such cell-based bioassays for water 
quality assessment has been successfully carried out in the past [26–28]. One study tested six endpoints of 
particular importance to human and environmental health (genotoxicity, estrogenicity, neurotoxicity, 
phytotoxicity, dioxin-like activity, and non-specific cell toxicity) to establish the efficacy of different 
water treatment barriers [26]. The authors applied the concept of TEQ by selecting one reference 
compound in each of the tests. The study concluded the bioanalytical tools to be reproducible and robust, 
and found the TEQ approach to be useful for assessing the removal of micro-pollutants in various 
treatment steps. Another recent study examined the suitability of cell-based bioassays to benchmark 
water quality and tested 103 unique in vitro bioassays, including induction of xenobiotic metabolism, 
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specific and reactive modes of toxic action, as well as activation of adaptive stress response pathways 
and system responses [28]. The study concluded that an ideal battery of bioassays should include 
sensitive bioassays covering a wide range of cellular toxicity pathways for effective water quality 
assessment. The widely applied AhR activation endpoint was found to be a relevant indicator of presence 
of chemicals and was suggested to be included in any routine battery of tests. Specific receptor-mediated 
modes of action—including effects related to estrogenic, glucocorticoid and antiandrogenic pathways—
showed the most promise for water quality screening applications. Additionally, the study identified 
oxidative stress response as a highly sensitive and selective indicator of environmental pollution [28].  
Once a toxic hazard has been established from use of the above screening tools, the key to successful 
characterization of chemical or chemical mixtures are analytical tools such as liquid/gas 
chromatography-mass spectrometry (LC/GC-MS) as well as computer-based tools for chemical structure 
elucidation. Non-target analysis by GC-MS in scan mode followed by mass spectral analysis using 
database searches can aid in identifying the unknowns present in the mixture that may significantly 
contribute to the observed toxicity. Structural elucidation and chemical identification can be aided 
greatly by using high resolution mass spectrometry (HRMS) [29]. In addition to instrumental techniques, 
programs such as quantitative structure-activity relationship (QSAR) have also been used in the past to 
predict and estimate the toxicity of chemical mixtures [30]. Although the latter tool can aid in identifying 
similar MOA of chemicals, the output from QSAR depends on proper input parameters and fails to 
address the problem of mixtures. Whereas this restricts the quantitative application of QSARs in 
environmental monitoring, the approach is quite useful for prioritizing and identifying chemicals that share 
common MOA. Combining EDA-like strategies with in silico analytical tools can further complement the 
traditional analysis of target compounds in environmental matrices. Combining these approaches then 
enables an identification and quantitation of harmful effect exerted by both single chemicals (including 
manufacturing byproducts and chemical degradates of commercial formulations) and chemical mixtures 
(like BFRs and other structurally similar organohalogens) featuring similar modes of toxic action. Such 
information then could inform both the design and regulation of industrial chemicals as well as 
enforcement of regulations leveled for environmental and human health protection [31]. However, 
bioassays are expensive and cannot replace the traditional monitoring approach when used in isolation. 
These tests should be included to identify chemicals causing an observed toxicity in environmental 
samples or where there is a high probability of toxicity to environmental end points, e.g., soils amended 
with contaminated sewage sludge and surface water receiving wastewater inputs. Though incorporating 
such techniques for regular monitoring is difficult and not economically feasible, testing samples yearly 
or biennially will benefit the regulatory community in prioritizing contaminants for future monitoring 
needs and to evaluate the effectiveness of legislative actions. 
4. Conclusions  
Polybrominated mono and bi-nuclear aromatic flame retardants of low molecular weight are prone to 
pose significant environmental and human health risks, no matter what minor modifications are made to 
the structure of their carbon backbone and its halogen substitution pattern. Learning from past failures 
and improving on existing monitoring strategies is a necessity for creating and implementing an effective 
regulatory framework and, ultimately, for designing more sustainable chemicals. Discontinuing 
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unnecessary uses of brominated flame retardants and developing non-halogenated alternatives may serve 
as the starting point for arriving at safer, greener and more sustainable consumer products. Fire 
retardation has essential applications in society but does not need to come at the expense of 
contaminating and harming the environment and human populations for multiple generations into the 
future. Analytical chemists and toxicologists have an opportunity to aid in the transition toward a more 
sustainable chemical future, by devising assays that capture multiple bad chemical players and that 
provide a composite measure for the toxicity these exert. Inclusion of such assays in routine monitoring 
and regulatory framework may provide opportunities to avoid harmful chemicals that are similar to 
legacy toxicants and to shorten the time taken for legislative actions, which on average takes some 14 years 
following first reports of significant risks posed [32].  
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